Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000046

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 14, 2018
Accepted (ET)
Aug 17, 2018 · 10:40 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 14, 2018P5,000$0.023A25,513,998D
Common StockAug 14, 2018P1,000$0.0235A25,514,998D
Common StockAug 14, 2018P1,000$0.0208A25,515,998D
Common StockAug 14, 2018P1,000$0.0199A25,516,998D
Common StockAug 14, 2018P2,000$0.0198A25,518,998D
Common StockAug 14, 2018P1,000$0.0199A25,519,998D
Common StockAug 14, 2018P1,000$0.0187A25,520,998D
Common StockAug 14, 2018P1,000$0.0191A25,521,998D
Common StockAug 14, 2018P1,000$0.0195A25,522,998D
Common StockAug 14, 2018P5,000$0.018A25,527,998D
Common StockAug 14, 2018P1,000$0.0176A25,528,998D
Common StockAug 14, 2018P5,000$0.0188A25,533,998D
Common StockAug 14, 2018P1,000$0.019A25,534,998D
Common StockAug 14, 2018P1,000$0.019A25,535,998D
Common StockAug 14, 2018P1,000$0.0194A25,536,998D
Common StockAug 14, 2018P2,000$0.0187A25,538,998D
Common StockAug 14, 2018P2,000$0.0197A25,540,998D
Common StockAug 14, 2018P1,000$0.0197A25,541,998D
Common StockAug 14, 2018P1,000$0.0197A25,542,998D
Common StockAug 14, 2018P2,000$0.0197A25,544,998D
Common StockAug 14, 2018P1,000$0.0194A25,545,998D
Common StockAug 14, 2018P2,000$0.0197A25,547,998D
Common StockAug 14, 2018P200$0.0197A25,548,198D
Common StockAug 14, 2018P5,000$0.02A25,553,198D
Common StockAug 14, 2018P2,000$0.0197A25,555,198D
Common StockAug 14, 2018P2,000$0.02A25,557,198D
Common StockAug 14, 2018P3,000$0.02A25,560,198D
Common StockAug 14, 2018P5,000$0.02A25,565,198D
Common StockAug 14, 2018P2,000$0.02A25,567,198D

Table II — derivative securities

No Table II lines on this filing.